Kedrion Biopharma
2001
FOUNDED
PRIVATE
STATUS
1K-5K
EMPLOYEES
Debt
LATEST DEAL TYPE
8
FINANCING ROUNDS
2
INVESTMENTS
Description
Producer of biological and pharmaceutical products. The company develops, produces and distributes human plasma-derived therapies for use in the treatment of Hemophilia, immunodeficiencies and other severe debilitating conditions.
Website
Formerly Known As
Farma Biagini
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
- Loc. Ai Conti
- Castelvecchio Pascoli
- 55051 Barga(Lucca)
- Italy
+39 0583 000000
Kedrion Biopharma Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Kedrion Biopharma‘s full profile, request access.
Request full access to PitchBookKedrion Biopharma Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000 00000000 000 | 31-Jul-2012 | 0000000000 | Clinics/Outpatient Services | ||
| Grifols (US Fractionation FVII & Plasma Collection Business) | 02-May-2011 | Buyout/LBO | Pharmaceuticals |
Kedrion Biopharma Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Kedrion Biopharma‘s full profile, request access.
Request full access to PitchBookKedrion Biopharma Executive Team (3)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Paolo Marcucci | President, Chairman, Managing Director & Chief Executive Officer | ||
| Simone Boaglio | Chief Financial Officer & Chief of Central Services |
1 Former Executive
You’re viewing 2 of 3 executives. Get the full list »Kedrion Biopharma Board Members (1)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 00000 0000000 | CDP Equity | Board Member | 000 0000 |